State of Ohio Board of Pharmacy Issues
From the Ohio Automated Rx Reporting System (OARRS) and e-prescribing to Terminal Distributor of Dangerous Drug licensure and pharmacy auto refill practices, the regulations and procedures of the impact the practice of medicine and the family physician office daily.
The following resources are provided to help members understand and navigate these regulations and procedures:
State of Ohio Board of Pharmacy Resources
- Annual Report FY 2021 and FY 2022
- Pharmacy Laws on Epinephrine Autoinjectors (2020)
- Annual Report on Opioid Prescribing in Ohio (2021)
- FAQ: Dispensing Naltrexone without a Prescription (June 18, 2019)
- Guidance Document: Hospitals Providing Naloxone Upon Discharge (October 17, 2016)
-
Responsible Person Requirements for Pain Management Clinics (April 1, 2015)
- Guidance Document: Controlled Substance Inventory Requirements (January 1, 2015)
-
Pain Management Clinics in Ohio A Special Report (July 2011 – December 2014)
- Guidance Document: Drug Take Back Programs (December 18, 2014)
- Rescheduling of Hydrocodone Combination Products (October 8, 2014)
- Guidance Document: Procurement of Epinephrine Autoinjectors by Schools and Camps (April 2014)
Additional Resources
Additional Information
- Ohio Law on the Sale of Dextromethorphan Products Effective September 30 (Weekly Family Medicine Update, August 31, 2021)
- State Pharmacy Board Issues FAQ on Pharmacist Consult Agreements (Weekly Family Medicine Update, December 22, 2020)
- Clarification on Mandatory E-Prescribing (Weekly Family Medicine Update, January 21, 2020)
- Notice about Extortion Scam (Weekly Family Medicine Update, December 10, 2019)
- Beware of Scam Targeting Prescribers Licensed in Ohio (Weekly Family Medicine Update, August 13, 2019)
- Circumstances Under Which Pharmacists Can Dispense Naltrexone (Weekly Family Medicine Update, June 11, 2019)
- Compounding Rules Go Back to CSI for Review (Weekly Family Medicine Update, April 16, 2019)
- Good Progress Made on Compounding Rules (Weekly Family Medicine Update, March 19, 2019)
- Compounding Rules Update (Weekly Family Medicine Update, March 5, 2019)
- OAFP Protests Prescribing Compounding Rules (Weekly Family Medicine Update, February 26, 2019)
- OAFP Signs on to Comment Letter Regarding Drug Distributor Rules (Weekly Family Medicine Update, March 27, 2018)
- OAFP Submits Comments to Pharmacy Board on Compounding Rules Draft (Weekly Family Medicine Update, March 27, 2018)
- OAFP Objects Again to Pharmacy Board Rules (Weekly Family Medicine Update, August 31, 2017)
- Response Received Relative to Letter Asserting Pharmacy Board Overreach (Weekly Family Medicine Update, January 17, 2017)
- OAFP Complains about Overreach of Pharmacy Board Rules (Weekly Family Medicine Update, December 20, 2016)
- Pharmacy Board Files Response on Compounding Rules with CSI (Weekly Family Medicine Update, August 30, 2016)
- Update on Pharmacy Compounding Rules (Weekly Family Medicine Update, August 16, 2016)
- Update on Pharmacy Compounding Rules (Weekly Family Medicine Update, August 9, 2016)
- OAFP Files Additional Comments on Compounding Rules (Weekly Family Medicine Update, August 2, 2016)
- Pharmacy Board Revises Proposed Compounding Rules (Weekly Family Medicine Update, July 26, 2016)
- OAFP Calls for Pharmacy Board to Indefinitely Suspend Compounding Rules (Weekly Family Medicine Update, July 12, 2016)
- Pharmacy Board Met June 6 to Consider Concerns Expressed About Compounding Rules (Weekly Family Medicine Update, June 7, 2016)
- Pharmacy Board to Revisit TDDD Licensure Rule (Weekly Family Medicine Update, May 17, 2016)
- Update on TDDD Licensing Requirement (Weekly Family Medicine Update, May 10, 2016)
- Board of Pharmacy Adopts New Rules on Drug Compounding by Prescribers (Weekly Family Medicine Update, March 8, 2016)